Kjetil Taskén

25PUBLICATIONS
128CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 19, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology.

Oskar Frisell, Eline Aas, Pia Sofie Henkel

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Jan 22, 2026
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity.

Elise Solli, Alessio Bevilacqua, Mathias Wenes

|Jan 07, 2026
Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Henk Van der Pol, Tina Kringelbach, Maria Martin Agudo

|Jul 09, 2025
Targeting proteostasis in multiple myeloma through inhibition of LTK.

Thea Kristin Våtsveen, Mariaserena Giliberto, Valgerdur Bjornsdottir

|Sep 08, 2024
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways.

Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff

Pageof 5

Frequent Collaborators

9 joint publications

Sigrid S Skånland

4 joint publications

Gro Live Fagereng

4 joint publications

Åslaug Helland

2 joint publications

Tina Kringelbach